Product Details
| Product Name: Tamoxifen | CAS No.: 10540-29-1 |
| EC-No.: 234-118-0 | Min. Order: 1kg |
| Purity: 99.99% | Supply Ability: 20 tons |
| Release date: 2025/08/20 |
Tamoxifen is a nonsteroidal estrogen antagonist of interest in the treatment of some forms of breast cancer. It is a Protein Kinase C inhibitor, and induces apoptosis in human malignant glioma cell lines.
In breast cancer, the gene repressor activity of tamoxifen against ERBB2 is dependent upon PAX2. Blocks estradiol-stimulated VEGF production in breast tumor cells. Protein kinase C inhibitor. Induces apoptosis in human malignant glioma cell lines. Tamoxifen and its metabolite 4-hydroxytamoxifen are selective estrogen response mo difiers (SERMs) that act as estrogen antagonists in mammary gland. Blocks estradiol-stimulated VEGF production in breast tumor cells.
Brand: Soarwin
CAS No.: 10540-29-1
EC Number: 234-118-0
Molecular Formula: C26H29NO
Density: 1.0630 (rough estimate)
Melting point: 97-98 °C(lit.)
Boiling point: 501.18°C (rough estimate)
Company Profile Introduction
You may like
-
CAS:54965-24-1
-
CAS:10540-29-1
-
CAS:10540-29-1
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
|
VIP6Y
|
RongNa Biotechnology Co.,Ltd
|
2026-07-10 | ||
|
VIP2Y
|
Shaanxi Xianhe Biotech Co., Ltd
|
2026-07-10 | ||
| $10.00 |
VIP1Y
|
Ningbo Qingteng Plastic Cost.,Ltd.
|
2026-07-10 | |
|
VIP1Y
|
Rongchuang International
|
2026-07-08 | ||
|
VIP3Y
|
ARCTIC EXPORTS INC
|
2026-07-07 | ||
|
VIP3Y
|
Shandong Hanjiang Chemical Co., Ltd
|
2026-06-25 | ||
| $5.00 |
Wuhan JiyunZen Tech Co., Ltd.
|
2026-04-10 | ||
|
VIP6Y
|
Zhejiang J&C Biological Technology Co.,Limited
|
2025-12-25 | ||
| $1.00 |
Wuhan Nutra Biotechnology Co.,Ltd
|
2024-11-01 | ||
| $3.00 |
Wuhan Cell Pharmaceutical Co., Ltd
|
2024-10-23 |
China- Since: 2025-02-19
- Address: 10-11, Building 4, No. 18 Jinshan Road, Longxi Street, Yubei District, Chongqing, China
+86-15790943001
crystal@sorawin.cn